CytoSorbents Corporation

CTSO US23283X2062

💰
Capitalization
Small-cap

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

🔗
Website
https://www.cytosorbents.com
Annual Performance 1
2021 2022 2023 2024 2025
-50% -63% -39% -15% 0%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
11
🙍
Insiders
9
Person Price Shares Total Published Completed
Mariani Peter J
CFO 		0.96
USD 		20,000
Bought 		19,294
USD 		13/12/2024 13/12/2024
Mariani Peter J
CFO 		0.89
USD 		20,000
Bought 		17,872
USD 		11/12/2024 12/12/2024
Mariani Peter J
CFO 		0.89
USD 		11,363
Bought 		10,103
USD 		11/12/2024 11/12/2024
Kim Jiny
O 		1.33
USD 		7,519
Bought 		10,000
USD 		13/12/2023 13/12/2023
Sobel Alan D.
O 		1.33
USD 		22,557
Bought 		30,001
USD 		13/12/2023 13/12/2023
Deliargyris Efthymios
CMO 		1.33
USD 		22,557
Bought 		30,001
USD 		13/12/2023 13/12/2023
Chan Phillip P.
CEO 		1.33
USD 		75,188
Bought 		100,000
USD 		13/12/2023 13/12/2023
Jones Edward Raymond
O 		1.33
USD 		7,519
Bought 		10,000
USD 		13/12/2023 13/12/2023
Bloch Kathleen P.
CFO 		1.33
USD 		37,594
Bought 		50,000
USD 		13/12/2023 13/12/2023
Bator Michael G.
O 		1.33
USD 		37,594
Bought 		50,000
USD 		13/12/2023 13/12/2023

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include CytoSorbents Corporation to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
-17% -12% 3% -75% -91% -82% -84%
Last 52W Low 52W High All-Time Low All-Time High β
0.95 0.81 1.29 0.81 1.29
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Chan Phillip P. 1 100,000.04 100,000.04 13/12/2023 13/12/2023
Bloch Kathleen P. 1 50,000.02 50,000.02 13/12/2023 13/12/2023
Bator Michael G. 1 50,000.02 50,000.02 13/12/2023 13/12/2023
Mariani Peter J 3 47,268.84 15,756.28 11/12/2024 13/12/2024
Deliargyris Efthymios 1 30,000.81 30,000.81 13/12/2023 13/12/2023
Sobel Alan D. 1 30,000.81 30,000.81 13/12/2023 13/12/2023
Capponi Vincent 1 25,000.01 25,000.01 13/12/2023 13/12/2023
Kim Jiny 1 10,000.27 10,000.27 13/12/2023 13/12/2023
Jones Edward Raymond 1 10,000.27 10,000.27 13/12/2023 13/12/2023

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Connected Companies 3
Name ISIN Ticker
Axogen, Inc. Common Stock US05463X1063 AXGN

3 the firms where the current insiders have executed transactions.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.